Skip to content
Triangle logo TriangleGet started
← Full study record

NCT05824689 · OUTCOME

Occurrence/Risk of Blood Stream Infection (BSI)

Fluoroquinolone Resistance Prevalence Study · Source last updated 2026-06-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Within 28 days of the transplantation

What was measured

The occurrence of Gram-negative BSI among the FRE carriers and FRE non-carriers

Groups in this outcome

Enrolled Participants

Subjects eligible for this study will meet the defined eligibility criteria to undergo autologous transplantation established at the transplant centers as per standard of care (SOC). All adult patients with a diagnosis of multiple myeloma undergoing autologous transplantation after dose-intense melphalan conditioning are candidates for enrollment into this study. These subjects will be approached for enrollment into this study by the transplant attending physician caring for the patient

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Enrolled Participants117

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Enrolled Participants3Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        3
denoms
  1. counts
    1. group Id
      OG000
      value
      117
    units
    Participants
description
The occurrence of Gram-negative BSI among the FRE carriers and FRE non-carriers
groups
  1. description
    Subjects eligible for this study will meet the defined eligibility criteria to undergo autologous transplantation established at the transplant centers as per standard of care (SOC). All adult patients with a diagnosis of multiple myeloma undergoing autologous transplantation after dose-intense melphalan conditioning are candidates for enrollment into this study. These subjects will be approached for enrollment into this study by the transplant attending physician caring for the patient
    id
    OG000
    title
    Enrolled Participants
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
Within 28 days of the transplantation
title
Occurrence/Risk of Blood Stream Infection (BSI)
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice